Inovio Covid-19 vaccine loss expected to fall on $45mn public D&O policy
  • X
  • LinkedIn
  • Show more sharing options
  • Print
  • X
  • LinkedIn
  • Free Trial
  • Log in

Inovio Covid-19 vaccine loss expected to fall on $45mn public D&O policy

John Hewitt Jones
July 02, 2020
  • X
  • LinkedIn
  • Show more sharing options
  • Print
  • X
  • LinkedIn
stock-image-crop-7a9333.png

Underwriters in the public D&O market are anticipating a payout following a class action lawsuit launched against US pharma giant Inovio, Inside P&C understands.

Market

Request a free trial:

Fuel a smarter strategy with our actionable market intelligence

    • Gain a competitive edge and accelerate decision-making
    • Be empowered by insights that transform confusion to clarity
    • Uncover growth opportunities and prepare for potential threats
Request a free trial Already a subscriber? Login now

Topics

NewsD&O (Directors and Officers)Specialty linesClaims and losses
JJ
John Hewitt Jones
Gift this article